Value-based insurance design for pharmacare

In this interview, Dr. Steve Morgan and Dr. Kai Yeung discuss a possible framework for pharmacare. They argue and explain that setting copayments based on drugs’ clinical and economic value can promote patient choice and encourage cost-conscious selections.Dr. Kai Yeung is a pharmacist and pharmaceutical economist at Kaiser Permanente Washington Health Research Institute in Seattle, Washington, and Dr. Steve Morgan is a health economist and professor of health policy at University of British Columbia, in Vancouver.They co-authored an analysis article published in the Canadian Medical Association Journal. Full article: www.cmaj.ca/lookup/doi/10.1503/cmaj.181721----------------------------------------------------------------------Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.Comments or questions? Text us.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

There are no comments yet.

Please log in to write the first comment.